Eugene Williams's most recent trade in ProMIS Neurosciences Inc. was a trade of 20,000 Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 40,000 | 40,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Purchase of securities on an exchange or from another person at price $ 4.65 per share. | 16 Dec 2022 | 1,000 | 158,930 | - | 4.7 | 4,650 | Common Shares |
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Purchase of securities on an exchange or from another person at price $ 4.64 per share. | 16 Dec 2022 | 1,000 | 159,930 | - | 4.6 | 4,640 | Common Shares |
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 12 Dec 2022 | 1,000 | 157,930 | - | 5.1 | 5,075 | Common Shares |
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Purchase of securities on an exchange or from another person at price $ 5.49 per share. | 07 Dec 2022 | 1,000 | 156,930 | - | 5.5 | 5,486 | Common Share |
| ProMIS Neurosciences Inc. | Eugene Williams | Director | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 02 Dec 2022 | 1,000 | 155,930 | - | 6.0 | 5,980 | Common Share |